We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A 76-year old patient underwent successful aortic heart valve replacement surgery,
becoming the first person in the world to receive the 3F Enable Aortic Heart
Valve, intended to eliminate the need for the cardiac surgeon to suture the
device into the aortic annulus of the patient in the usual manner, saving an
average of 30 minutes or more of cardiopulmonary bypass time.
Syneron Medical, a maker of medical aesthetic devices using elos (electro-optical
synergy) technology, has announced that American Laser Centers (ALC) purchased
$1.5 million worth of elos aesthetic devices, including the Aurora and Comet
systems.
A common screening test failed to detect potentially cancerous colon growths
95 percent of the time, falsely reassuring patients and doctors, according to
a new study.
Ciphergen Biosystems announced that the National
Cancer Institute's Early Detection Research Network reported completion of the
first phase of its development of a proteomics platform using Ciphergen's SELDI
ProteinChip System for the detection of prostate cancer.
Elekta of Sweden has said it would acquire Nasdaq-listed IMPAC Medical for $24
a share in cash, equating to an enterprise value of $190 million, a premium
of 22 percent on the U.S. group's last closing price.
Abbott will begin enrolling patients during the first quarter of 2005 in its
asymptomatic carotid trial, ACT I. The first trial of its kind, this multicenter,
randomized trial will compare carotid artery stenting to carotid artery surgery
in asymptomatic patients -- those who have not displayed symptoms of a stroke
but are at-risk -- who normally would be referred for surgery.
Thermage, a maker of innovative aesthetic devices based on proprietary radiofrequency
technology, characterized the countersuit filed Jan. 10 by Syneron as without
merit.
Milestone Scientific announced that the results of a second independent pilot
clinical study have confirmed the efficacy of its CompuFlo pressure/force computer-controlled
anesthetic delivery system in determining the pressure of the epidural space.
ManthaMed, a Canadian distributor devoted to the promotion of diagnostic testing
designed to detect and monitor certain medical conditions, has added another
medical device to its product line.
Unilens Vision has announced the launch of a new soft, multifocal toric contact
lens that will provide astigmatic patients, who now have presbyopia, with all-day
comfort, ease of fit and optimum visual acuity at every distance.
Acceleration Therapeutics has announced that a published study using its AT-101
passive exercise device showed, for the first time, that the AT-101 produces
an important benefit that also occurs with active exercise.
Eyeonics, the developer of the crystalens, the first and only FDA-approved accommodating
intraocular lens, has announced that more than 13,000 crystalens were implanted
in the U.S. during the company's first year in the U.S. market.